Companies / Origin Bio
Origin Bio
San Francisco, CA, United States
Origin Bio develops a data engine to predict cancer drug responses by mapping tumor biology using real patient tissue
Origin Bio, based in San Francisco, CA, United States, has 2 investors on file, among them Glasswing Ventures and Y Combinator. Its latest round on record is Seed, 1 Jan 2026. Its site was last checked 13 Nov 2026: site answers.
Funding
1 round on recordRound sizes and total raised are on Fundup AI, our sister product for funding data.
Investors
2 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital | |
| Page + round | Accelerator |
More from Glasswing Ventures
70 companies on its checked portfolioIts portfolio leans to AI & Machine Learning (32%), Cybersecurity (19%), Enterprise Software (9%).
See Glasswing Ventures' full profile · Who invests alongside it
More from Y Combinator
5,167 companies on its checked portfolioIts portfolio leans to AI & Machine Learning (26%), Fintech (13%), Healthcare & Biotech (11%).
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Origin Bio and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Glasswing Ventures adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/origin.bio/investors
# also
GET /v1/companies/origin.bio
GET /v1/companies/origin.bio/news